Potential Utility of the Tau Deposit Tracer [18F]T807 (aka [18F]AV-1451) as a PET Biomarker for Neurodegeneration in Clinical Trials

被引:0
|
作者
Mintun, Mark [1 ]
Devous, Michael, Sr. [1 ]
Attardo, Giorgio [1 ]
Joshi, Abhinay [1 ]
Schwarz, Adam [1 ]
Shcherbinin, Sergey [1 ]
Siderowf, Andrew [1 ]
Lin, Yin Guo [1 ]
Liang, Qianwa [1 ]
Conway, Kelly [1 ]
Gomez, Felipe [1 ]
Pontecorvo, Michael [1 ]
机构
[1] Avid Radiopharmaceut, Philadelphia, PA USA
关键词
tau; imaging; PET; neurodegeneration;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
M145
引用
收藏
页码:S207 / S208
页数:2
相关论文
共 50 条
  • [21] Automated Radiosyntheses of [18F]AV-1451([18F]T-807) Analogs as PHF-Tau Protein Imaging Agents using Tracerlab FXN Module
    Huang, Ya-Yao
    Chiu, Ching-Hong
    Tsai, Chia-Ling
    Chang, Yu-Ning
    Chou, Shu-Cheng
    Hsin, Ling-Wei
    Yen, Ruoh-Fang
    Shiue, Chyng-Yann
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2017, 60 : S209 - S209
  • [22] Synthesis of T807 for preparation of [18F]T807, a tau PET imaging agent for Alzheimer's disease
    Gao, Mingzhang
    Wang, Min
    Zheng, Qi-Huang
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [23] Comparing quantitative measures of global and regional tau binding for 18F AV-1451 PET scans
    Chen, Jingyun
    Li, Yi
    Pirraglia, Elizabeth
    Rusinek, Henry
    De Leon, Mony
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [24] [18F]AV-1451 PET imaging of tau in progressive supranuclear palsy and Alzheimer's disease
    Rowe, J. B.
    Rodriguez, P. Vazquez
    Hong, Y. T.
    Borchert, R. J.
    Sami, S.
    Bevan-Jones, W. R.
    Jones, S. P.
    Arnold, R.
    Surendranathan, A.
    Mak, E.
    Li, S.
    Fryer, T.
    O'Brien, J.
    Passamonti, L.
    MOVEMENT DISORDERS, 2016, 31 : S375 - S376
  • [25] Comparison of [18F]AV-1451 PET with HDFT in chronic TBI subjects
    Mountz, James
    Minhas, Davneet
    Laymon, Charles
    Beers, Sue
    Puccio, Ava
    Edelman, Kathryn
    Sharpless, Jane
    Lopresti, Brian
    Puffer, Ross
    Schneider, Walter
    Mathis, Chester
    Okonkwo, David
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [26] [18F]AV-1451 Binding and Postmortem Pathology of CBD
    Coakeley, Sarah
    Ang, Lee Cyn
    Jansen, Gerard H.
    Cho, Sang Soo
    Lang, Anthony E.
    Houle, Sylvain
    Kalia, Lorraine V.
    Strafella, Antonio P.
    MOVEMENT DISORDERS, 2018, 33 (08) : 1360 - 1361
  • [27] [18F]T807 ([18F]AV-1451) and Fluorescent Analog T726 Bind to PHF-Tau but Not TDP-43 in Alzheimer's and FTD Post-Mortem Brain Tissue Sections
    Liang, Qianwa
    Lin, Yin-Guo
    Gomez, Felipe
    Bigio, Eileen
    Beach, Thomas
    Mintun, Mark
    Attardo, Giorgio
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [28] Tau [18F]AV-1451 PET uptake in patients with suspected 4-repeat tauopathy
    McMillan, C.
    Schonhaut, D.
    Russell, D.
    Boxer, A.
    Litvan, I.
    Roberson, E.
    Nasrallah, I.
    Siderowf, A.
    Devous, M.
    Grossman, M.
    Rabinovici, G.
    JOURNAL OF NEUROCHEMISTRY, 2016, 138 : 375 - 375
  • [29] Principal component analysis of [18F]-AV-1451 tau PET in Alzheimer disease and frontotemporal dementia
    Friedrichsen, K.
    Mishra, S.
    Ghoshal, N.
    Gordon, B.
    Joseph-Mathurin, N.
    Su, Y.
    Christensen, J.
    Aldea, P.
    McConathy, J.
    Ances, B.
    Cairns, N.
    Morris, J.
    Benzinger, T.
    JOURNAL OF NEUROCHEMISTRY, 2016, 138 : 383 - 384
  • [30] [18F]AV-1451 Tau Positron Emission Tomography in Progressive Supranuclear Palsy
    Whitwell, Jennifer L.
    Lowe, Val J.
    Tosakulwong, Nirubol
    Weigand, Stephen D.
    Senjem, Matthew L.
    Schwarz, Christopher G.
    Spychalla, Anthony J.
    Petersen, Ronald C.
    Jack, Clifford R., Jr.
    Josephs, Keith A.
    MOVEMENT DISORDERS, 2017, 32 (01) : 124 - 133